90 DAY READMISSION WITH TRIMODAL THERAPY IN MUSCLE INVASIVE BLADDER CANCER.

Authors

Camille Azar Callaway, LSU Health Sciences Center - New OrleansFollow
Brett Christopher Haaga, LSU Health Sciences Center - New OrleansFollow
Mary Beth Westerman, LSU Health Sciences Center - New OrleansFollow
Scott Delacroix, LSU Health Sciences Center - New OrleansFollow
Jaya Mishra, LSU Health Sciences Center - New OrleansFollow
Jessie Gills, LSU Health Sciences Center - New OrleansFollow
Carrie Marquette, LSU Health Sciences Center - New OrleansFollow
Siddhartha Padmanabha, LSU Health Sciences Center - New OrleansFollow
Paul Monsour, LSU Health Sciences Center - New Orleans

Document Type

Conference Proceeding

Publication Date

3-1-2025

Publication Title

Urologic Oncology

Abstract

25th annual meeting of the SUO; December 4 - 6, 2024; Dallas, TX

First Page

44

Volume

43

Issue

3

Publisher

Elsevier B.V.

Comments

SUO Abstracts - 109

Recommended Citation

Callaway, Camille Azar; Haaga, Brett Christopher; Westerman, Mary Beth; Delacroix, Scott; Mishra, Jaya; Gills, Jessie; Marquette, Carrie; Padmanabha, Siddhartha; and Monsour, Paul, "90 DAY READMISSION WITH TRIMODAL THERAPY IN MUSCLE INVASIVE BLADDER CANCER." (2025). School of Medicine Faculty Publications. 3609.
https://digitalscholar.lsuhsc.edu/som_facpubs/3609
10.1016/j.urolonc.2024.12.112